Publication | Closed Access

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

Radiation MedicineRadiation TherapyMedicineMetronomic TherapyClinical Radiation OncologyOncologyRadiation OncologyLung CancerSafety EvaluationLine Chemo-radiotherapy Regimen